Article

Researchers Identify Rules That Govern Immune Response

Author(s):

Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.

Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.

The research, led by Gerard C. L. Wong, professor of bioengineering and chemistry, UCLA, UCLA’s Henry Samueli School of Engineering and Applied Science, and California NanoSystems Institute, was published in the journal Nature Materials.

Using synchrotron X-ray scattering and other methods, the researchers “determined that a broad range of molecules, both organic and inorganic, can organize self-DNA into a liquid crystalline structure that binds strongly” to TLR9 receptors, which induce the interferon response.

This crystalline structure protects the DNA, thus strengthening the immune response.

If researchers can learn more about how these molecules are organized, it could pave the way for more effective treatments for lupus, psoriasis, and other autoimmune disorders.

Wong commented, “Our research has identified a set of rules that tell us what types of molecules or materials can set off this aspect of the immune system. This new knowledge will make it easier to design new therapeutic strategies to control immune responses.”

Furthermore, Nathan Schmidt, another study author, said, “Our colleagues had established empirically that certain molecules were activating self-DNA and triggering responses in disorders such as lupus and psoriasis. We were able to elucidate something that was poorly understood — a key to triggering the immune response is that the molecules must arrange the DNA so that the receptors bind to them strongly.”

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.